Categories
Anticancer Drugs Oncology Palonosetron Pharmacology Physiotherapy

Palonosetron Clinical Trials Effect (Liver)

In this article we will discuss Palonosetron Clinical Trials Effect (Liver)

In this article, we will discuss Palonosetron Clinical Trials Effect (Liver). So, let’s get started.

Liver: < 1%: transient, asymptomatic increases in AST and/or ALT and bilirubin. These changes occurred predominantly in patients receiving highly emetogenic chemotherapy.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.